d2 rhiannon carmody

12

Click here to load reader

Upload: jacob-reynolds

Post on 15-Apr-2017

219 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: D2 Rhiannon Carmody

INFOSYS.110 BUSINESS SYSTEMS: DELIVERABLE 2: BUSINESS SECTION2014

Name Rhiannon CarmodyNetID Rcar720Group Number: 231Website Link: http://infosys1102014s1group231.blogspot.co.nz/

Tutorial DetailsTutor: Day: Time:Kit-Wah Huang Wednesday 12 pm

Time Spent on Assignment: 8 hours Word Count: 1465

Page 2: D2 Rhiannon Carmody

A SMART DIABETIC WRISTBANDINTRODUCTION

Those who are suffereing from diabetes do not have available acces to techonology that allows for regular and accurate monitoring to be made for their blood sugar levels. This is a problem as there are millions of people around the world and over 225,00 people suffering from this condition in New Zealand (Diabetes New Zealand, 2008). A solution to this is by creating a techonolgy that can allow diabetics to dose themselves more accurately and monitor several other inputs to maintain and manage their diabetes. This techonology will be incorporated into “A Smart Wristband”.

3. BUSINESS SECTION

3.1 Vision

We intend to provide the world’s most accurate and reliable technology for those suffering from diabetes. Changing the way of maintaining blood sugar levels providing an easy, precise and most innovative technology available to all. Also to improve the quality of life of diabetic sufferers all around the world.

3.2 Industry Analysis: Medical Devices Industry

Industry: Medical Devices Industry. Those who supply technology to provide healthcare devices.

Force: High/Low: Justification:

Buyer power: Low As this is the only product that is available that

provides this techonology if the buyer needs it

there are few places to purchase it from

therefore their choices are limited resulting is low

buyer power. The only other devices available

that are similar do not provide the same accuracy

and detailed evaluation of the blood sugar levels.

(Medical Devices, 2014)

Supplier power: Low There are many places where the techonology to

create this product are found. As this is just a

combination of different devices of testing into

Page 3: D2 Rhiannon Carmody

one product (Qualified Supplier Directory, 2014 )

Threat of new entrants: Low As this is an innovative idea on monitoring and

maintain diabetes, there is a low threat of new

entrants as it is hard for a new firm to come into

an industry and start up a new technology to

produce. This is because you need the medical

knowledge and supplies to be able to create this

and it is very hard to get into this industry.

Threat of substitutes: High As many other attempts to create techonolgy or

apps to do these things designed in this product

and have failed this shows there arent many

substitute products. (Health apps don’t save

people, people do, Bradley 2013). Although there

are alternative ways of montioring your diabetes

none of these are as effiecient as the one as

proposed but they are still effective in a way of

monitoring health just not as accurate, people

can still maintain with the previous techonolgy

therefore the threat of substitutes is high.

Rivalry among existing

competitors:

Low As there is not many existing competitors in this

industry this means the rivalry is low because

there arent many to compete with. The only

existing competitors are those who sell inferior

subsitute products such as the continuous

glucose monitoring devices. (Diabetes care, 2010)

Overall attractiveness of the industry: This industry is fairly attractive as the buyer power is low, supplier power is low, rivalry is low and the treat of new entrants is also low this means that there isnt much of a risk to enter this industry and there arent many barriers to entry. Although there is risk in entering the industry as there is a high threat of substitute products, these products are

Page 4: D2 Rhiannon Carmody

inferior and out of date. It is likey that any new innovation would out do the existing products. Therefore entering this industry could be very profitable and a good decision for a firm.

3.3 Customers and Their Needs

The target group of customers for this industry are those in the medical sector suffering from type 2 diabetes as this product provides technology specialised for these people. The most important factor for people who suffer from this illness is maintaining and managing it (Diabetes New Zealand, 2008). The needs of these targeted customers is to have something that can monitor their type two diabetes accurately and precisely, this relieving any stress relating to their treatment.

3.4 The Product and Service

As it is often hard for people with busy lives and other things on their minds rather then monitoring their blood sugar levels, the “Smart Diabetic Wrist band” is where this comes into place, giving these targeted customers something they no longer need to be concerned about as the wristband does all the work for them. This product is easy to operate as it is an automatic techonology that monitors the blood sugar levels within the wristband and evaluates is treatment is needed. This removing the stress and panic from the diabetes sufferers lives, which is one of the main concerns of these people.

3.5 Suppliers and Partners

Suppliers would be those who supply medical screening/monitoring equipment such as FDI Medical and Qmed. These are who supplies what is needed to create the products and make it possible for the product to be made and distributed. Whereas the partners would be those such as diabetic researchers or specialists, they can partner up with the company to reinforce to the quality of the product, to enusre it actually works and is the best option to use. And can alos provide feedback on how to improve the product. Another partner could be the medical board, suggesting this as the best option for care for patients that suffer from diabetes.

3.6 Strategy:

As this company is providing a solution to a narrow target of customers, those suffering from diabetes and because this is a new innovation of medical care, creating a better lifestyle, also the equipment and software that will be needed for this will be fairly costly, resulting in the cost strategy being in the high cost section. It is also high cost as this is an improvement on life and those that are willing to make there life easier would be willing to pay highly for this.

The overall strategy is therefore focused strategy (differentiation).

3.7 Value Chain Activity:

The most important value chain activity for this business is technology devolopment. The reason for this is as stated in the vision statement it is important to provide the easiest, most reliable and innovative technology available. Because of this, technology is the most important factor as the technology used for the wristband must be up to date and as accurate as possible to provide the best possible outcome for customers to use.

Page 5: D2 Rhiannon Carmody

3.8 Business Processes

3.8.1. A key business process is the testing process. This is an important process as it is when the

trailing stage is happening to see how well the product represents the vision of the company and

how well it’s going work. If it is fit for purpose, safe and operational for customers.

Page 6: D2 Rhiannon Carmody

3.8.2. Another key business process is the Product analysis process. This is an important process as

the vision is to be the most innovative technology therefore there needs to be ongoing research and

develop to be able to update and maintain the high standard of technology they provide.

Page 7: D2 Rhiannon Carmody

3.9 Functionalities

3.9.1. THE PRODUCT TESTING PROCESS

Determines whether the product is ready for distributing. Prevents possible problems that could occur because its been tested.

3.9.2. THE TECHNOLOGY DEVELOPMENT PROCESS

Provides the opportunity to stay the most innovative technology. Improves the product

3.10 Systems

3.10.1. THE MARKET ANALYSIS SYSTEM – this is the researching and devoloping stage to ensure the product is the best it can be comparing it to subsitutes and innovative ideas.

3.10.2. THE PRODUCT ANALYSIS SYSTEM – Ensuring that the product is working and ready to

sell to the targeted customers.

3.10.3. THE TECHNOLOGY ANALYSIS SYSTEM - Focuses on making sure the product is working to

its best potential within the market and seeing what improvements are available to implement.

Page 8: D2 Rhiannon Carmody

3.11. Summary Table: Value Chain to Systems

Value Chain Activity

Processes Functionalities Specific Information System(s)

Broad Information System(s)

Techonology

(Research

And

Devolopment

)

1. Testing Process 1. Determines whether the product is ready for distributing.

2. Prevents possible problems that could occur because its been tested.

Inventory Distributing system

Product evaluation systems.

Decision support system

Supply chain management system

2. Development

process

3. Provides the opportunity to stay the most innovative technology.

4. Improves the product

Maintence and improvement systems

Research and improvement systems.

Enterprise information system

Decision support sytem

Page 9: D2 Rhiannon Carmody

CONCLUSION

As this is for people who suffer from diabetes the main factor of this product is the innovative

technology incorporating the different testing mechanisms within the wristband to allow the

most accurate and reliable readings to determine when and how much treatment they require

to take. Because of this information systems and information technolgy are very important

factors as these are the only ways to ensure these needs are met by keeping up to date with

technology and producing this product in the most efficient way possible.

REFERENCES

1. Type 2 diabetes - Diabetes New Zealand. (2014) Retrieved from http://www.diabetes.org.nz/about_diabetes/type_2_diabetes

2. U S Food and Drug Administration Home Page. (2014). Retrieved from http://www.fda.gov/

3. Qmed is the world's only directory of pre-qualified suppliers to the medical device and in vitro diagnostics industry. | Qmed. (2014). Retrieved from http://www.qmed.com/supplier-directory

4. Bradley, R. (2013). HEALTH APPS DON’T SAVE PEOLE, PEOPLE DO. Fortune International (Asia), 168 (6), 18.

5. Continuous Glucose Monitors - Continuous Glucose Monitoring. (2010). Retrieved from http://www.medica.co.nz/diabetes-care/continuous-glucose-monitoring/continuous-glucose-monitors.html